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A prevailing cellular model of learning involves modification of
synapse strength, induced by patterns of neuronal activity dur-
ing training, which encodes information in neural networks1,2.
Understanding the molecular mechanisms used by synapses to
detect altered patterns of firing, and how signaling cascades then
change the strength of synaptic transmission, may provide basic
insights into this model and illuminate pathological mechanisms
that occur in human learning impairments and other psychiatric
disorders3. Considerable attention has focused on the NMDA
subtype of glutamate receptor4 because its blockade in the hip-
pocampus impairs both synaptic plasticity and learning1. This
receptor channel, which allows calcium influx into the postsy-
naptic spine, regulates kinases, phosphatases and other enzymes,
which then regulate AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxasole-4-propionic acid) glutamate receptors (AMPARs), spine
cytoskeletal changes, translation, transcription and other events.
These diverse actions indicate the NMDAR couples to multiple
intracellular signaling pathways. Moreover, in a physiological set-
ting, these signals must be subtly integrated, as shown by elec-
trophysiological studies in CA3–CA1 synapses of the
hippocampus, where low-frequency synaptic stimulation results
in NMDAR-dependent long-term depression (LTD) and higher
frequencies in long-term potentiation (LTP) of synaptic strength2.
LTP comprises a series of temporally distinct processes that
can broadly be separated into ‘induction’ and ‘maintenance’ phas-
es. The induction phase includes the train of stimuli that acti-
vate the NMDA receptor, which lasts for seconds or less, and a
period of minutes during which second messenger pathways act,
leading to a new stable level of synapse strength in the mainte-
nance phase. Unlike the induction phase, the maintenance phase
is resistant to inhibitors of second messengers, such as kinases
and phosphatases, although it is sensitive to inhibitors of RNA
and protein synthesis for the first two to three hours, indicating
a role for new gene expression1,2. In parallel with this require-
ment for gene expression in the late phases of LTP, the NMDAR
is required for transcriptional activation and dendritic trafficking
of mRNAs and proteins such as Arg3.1/Arc and Homer/Vesl. A
recent review5 of the molecular mechanisms of LTP highlighted
the large number of implicated molecules and the lack of a sat-
isfying model. In addition to neurotransmitter receptors and
multiple signaling proteins, this list of molecules included adhe-
sion and structural proteins. An approach to the problem of
understanding the molecular basis of LTP and its signaling path-
ways is to combine a functional genetic and pharmacological dis-
section with structural analysis of the organization of synaptic
molecules.
Assembly of receptors with signal transduction proteins into
large multiprotein complexes has emerged as a general mecha-
nism of cellular signaling6. The NMDAR binds postsynaptic pro-
teins7–9, including postsynaptic density 95 (PSD-95), which
regulates synaptic plasticity in mutant mice10, consistent with the
hypothesis that a signaling complex regulates synaptic plasticity
and learning. To further explore this model, we have isolated
NMDAR–PSD-95 complexes from mouse brain and analyzed
their properties using proteomic techniques, which are power-
ful tools for analysis of large protein complexes11,12. This approach
allows the detection of protein interactions that require post-
translational modifications such as phosphorylation (for exam-
ple, SH2 binding of PI3-kinase to NMDAR subunits13) and lipid
modification (for instance, in PSD-95; ref. 14) and ternary or
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weak interactions undetected by 2-hybrid screens11, which have
been extensively used to identify NMDAR and PSD-95 binding
partners7–9. Moreover, biochemical characterization of NRC from
brain is required for analysis of mice carrying mutations affecting
the complexes as well as other in vivo analyses.
Developments in high-sensitivity mass spectrometry, particu-
larly nano-electrospray mass spectrometry coupled with search
engines to access the huge amount of data produced by the genome
sequencing projects, have fueled the growth of proteomics15. Ini-
tially defined as the protein complement of a genome, the term
proteome has been generalized to encompass any large-scale
approach to protein characterization. Proteins may exist as dis-
crete known proteins in databases (such as SwissProt), as complete
or partial sequences in EST databases (for example, dbEST), or as
putative open reading frames in genome databases. All three are
accessible to searching by combinations of mass and partial
sequence information generated by mass spectrometry, searching
the protein databases directly and translating the DNA sequences
in six frames. The required numerical search attributes are gener-
ated by specific proteolytic digestion of the protein, and subse-
quent analysis of the resulting peptide pool by mass spectrometry.
Two measurements are usually made; the first is the mass of as
many peptides as possible. This peptide mass fingerprint (PMF)
alone may be sufficient to identify the original protein, particu-
larly if the protein was isolated in a relatively pure state by, for
example, two-dimensional gel electrophoresis. More often though,
proteins are available only as mixtures, and here PMFs are less use-
ful. In this case, mass and partial sequence information are gener-
ated by tandem mass spectrometry (MS/MS) and combined to
provide powerful discriminating input for mass spectrometry
search engines. This latter approach is sufficiently robust to deal
with simple mixtures, and if combined with on-line separation
techniques can deal with very complex protein mixtures, for exam-
ple, from bands from one-dimensional gels, or even total protein
complexes. This is a more appropriate approach for searching EST
databases, which rarely contain full-length protein sequences.
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Fig. 1. Basic composition of NRC isolated from mouse brain. (a, b) Protein staining of SDS-PAGE (a, 12%; b, 6%) from immunoaffinity (IA), immuno-
precipitation (IP) and NR2B peptide affinity (Pep) isolation of NMDAR from mouse brain extracts (Ex). Negative controls are MAP-NR1 Ig bound to
protein G-sepharose (Ig+G) and extracts bound to protein G-sepharose (Ex+G). Arrowheads indicate position of Ig species. A complex mixture of
specific binding proteins were observed, mainly in the range above 70 kD, and were analyzed by mass spectrometry (g; Table 2). (c) Immunoblot
analysis of NMDAR subunits and MAGUK proteins in NRC. NR1, NR2A, NR2B, PSD-95 and Chapsyn-110 were detected. The NRC from 5 mg of
starting material, 50 µg of protein loaded in total extract (Ex), was isolated and loaded per lane (IA, IP, Pep). Yield and enrichment cannot be calcu-
lated because the IA, IP and Pep samples contained interfering Ig and peptide, and thus did not permit protein quantitation. (d) Immunoblot analysis
of PSD-95 binding proteins in NRC. We detected nNOS, SynGAP, GKAP and Citron. (e) Immunoblot analysis of AMPA receptor subunits and GRIP
in NRC. GluR1, GluR2, GluR2/3, GluR4 and GRIP were readily detected in the starting material (Ex) but not in the three NRC preparations. 
(f) Immunoblot analysis of mGluR1 receptor and Homer proteins in NRC. We detected mGluR1α and Homer, indicating that the NRC includes
metabotropic glutamate receptors but not AMPA receptors. (g) Protein staining of NRC (6% SDS–PAGE) showing position (arrowheads) of bands
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RESULTS
We began by comparing methods for NRC purification from
mouse brain, including standard FPLC chromatography, affinity
chromatography with NMDAR ligands, immunoaffinity chro-
matography with purified antibodies, large-scale immunopre-
cipitation and peptide affinity (H.H. & S.G.N.G., unpublished
data). The clearest results were produced by three methods:
immunoaffinity chromatography, immunoprecipitation with an
antibody directed against the NMDA R1 subunit, and peptide
affinity based on the structure of the NMDA R2B subunit C ter-
minus that binds to the NMDAR-binding protein PSD-95 
(Fig. 1). Analysis of individual fractions on sodium dodecyl sul-
fate–polyacrylamide gels (SDS–PAGE) showed that the purified
material was very complex (Fig. 1a and b, lanes IA, IP, Pep) com-
pared to unspecific interaction of extracted proteins with pro-
tein G-sepharose used in immunoprecipitations (lane Ex+G) or
blocked affigel-10 used in antibody and pep-
tide affinity purification (Fig. 1), as well as
other peptides and antibodies (data not
shown). The integrity of the complexes and
specificity of protein interactions were exam-
ined. NMDAR subunits (NR1, NR2A,
NR2B) and their reported interacting pro-
teins7–9 (PSD-95, Chapsyn-110/PSD-93,
calmodulin, α-actinin 2, calcium/calmod-
ulin kinase II (CaMKII), phospholipase Cγ)
were readily detected (Fig. 1c and Table 1),
and PSD-95 binding proteins including
nNOS, SynGAP, SAPAP/GKAP and Citron were also found 
(Fig. 1d). We next examined AMPA subunits (GluR1–4) and
their cognate adapter protein GRIP16, which were undetected in
the NRC despite their abundance in the extract (Fig. 1e). Simi-
larly, we did not detect NMDAR complex proteins in immuno-
precipitations with AMPAR-specific antibodies (data not shown).
Kainate receptor subunits (GluR6/7) were detected, consistent
with reports that PSD-95 binds these subunits17. The
metabotropic (mGluR1α) receptors and their cognate binding
partner Homer/Vesl, were found in the NRC (Fig. 1f), consistent
with reports from 2-hybrid screening that Homer binds Shank,
which can bind GKAP to PSD-95 (refs. 18, 19). Therefore the
NMDAR and mGluR receptors are associated in distinct com-
plexes from AMPA receptors.
We next identified novel components of the NRC using two
strategies: a western blotting screen for candidate proteins involved
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Fig. 2. Mass spectrometry analysis of the NRC.
(a) Base peak chromatograms generated in MS
survey mode (example from trypsin digestion
products of a 90 kD protein band) The two most
intense ions in each MS scan are automatically
selected for collision-induced fragmentation and
analysis in MS/MS mode (LC-MS/MS; b). (b) Base
peak chromatograms of one of the two MS/MS
channels. The labels at 38.2 min and 42.6 min
correlate with two peptides that were selected
to generate peptide sequence information. 
(c, d) Corresponding MS/MS spectra obtained
from the precursors eluting at these times. 
(c) Averaged MS/MS spectrum obtained from
peak eluting at 42.6 min in (b). A doubly charged
ion at mass to charge ratio (m/z) 809.72, corre-
sponding to a peptide of 1617.44 D, was selected
for fragmentation by collision-induced dissocia-
tion. The fragment ions that originate either
from the N terminus (b type ions) or the C ter-
minus (y” type ions) correspond to an amino-
acid sequence that was identified using the
Mascot database search program. In this
instance, the MS/MS spectrum matched the pep-
tide sequence VNDSILFVNEVDVR from PSD-95
residues 113–126 (accession number Q62108).
(d) Example of a novel NRC protein identified
from the averaged MS/MS spectrum obtained
from the peak eluting at 38.2 min in (b). The
observed doubly charged precursor ion at m/z
538.68, relating to a 1071.65 D peptide, was iden-
tified by Mascot search program as the sequence
DLKEILTLK, which matches APPL, an adaptor
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Table 1. Summary of molecular composition of the NRC.
Protein Mr (kD) Ex IA IP Pep Ab Binding partner
Glutamate receptors
1 NR1 120 +++ +++ +++ +++ a 2, 3, 18, 35, 68, 95, 96, 101
2 NR2A 180 +++ +++ +++ +++ b 1, 3, 10, 11, 12, 35, 73, 96
3 NR2B 180 +++ +++ +++ +++ c 1, 2, 10, 11, 12, 35, 43, 95, 71, 73, 96, 101
4 GluR1 108 +++ – – – d
5 GluR2 102 +++ – – – d
6 GluR2/3 102 +++ – – – e
7 GluR4 108 +++ – – – d
8 GluR6 + 7 117 +++ + + + b 10, 12
9 mGluR1α 200 +++ +++ +++ ++ d 15, 68, 73, 101
Scaffolding and adaptors
10 PSD-95 95 +++ +++ +++ +++ f 2, 3, 8, 10, 11, 12, 13, 65, 69, 75
11 ChapSyn110 / PSD-93 110 +++ +++ +++ +++ g 2, 3, 10, 69
12 Sap102 115 +++ + + +++ h 2, 3, 8, 10, 13, 65, 68
13 GKAP / SAPAP 95–140 +++ +++ ++ +++ e 10, 12, 14
14 Shank 200 +++ +++ +++ +++ i 13, 15, 102
15 Homer 28/45 +++ ++ ++ ++ j 9, 15, 14
16 GRIP 120 +++ – – – e
17 ABP (GRIP2) 95–130 +++ – – – k
18 Yotiao 200 +++ +++ +++ +++ l 1, 25, 37
19 AKAP150 150 +++ +++ +++ +++ l 25, 26–34, 39, 68
20 NSF 83 +++ ++ ++ +++ m 5, 20
PKA 18, 19, 92
21 PKA catalytic subunit 40 +++ ++ ++ ++ f
22 PKA-R1α and β 48 +++ ch ch – f
23 PKA-R1a-α 49 +++ ch ch – f
24 PKA-R2α 51 +++ ch ch – f
25 PKA-R2β 53 +++ ++ ++ ++ f
PKC 19, 105
26 PKC α 82 +++ – – – f
27 PKC β 80 +++ ++ ++ ++ f
28 PKC γ 80 +++ +++ +++ +++ f
29 PKC δ 78 +++ – – – f
30 PKC ε 90 +++ ++ ++ ++ f
31 PKC η 82 +++ – – – f
32 PKC θ 79 +++ – – – f
33 PKC ι 74 +++ – – – f
34 PKC λ 74 +++ – – – f
CaM kinase 1, 2, 3, 65, 68, 69
35 CaM kinase II β 60 +++ +++ +++ +++ f
36 phospho-CaM kinase II 60 +++ ++ ++ ++ n
Phosphatases
37 PP1 36 +++ +++ +++ +++ f 18
38 PP2A 36 +++ +++ +++ + f
39 PP2B (calcineurin) 61 +++ + + + f 19
40 PP5 50 +++ ++ ++ ++ o
41 PTP1B 50 +++ ch ch – b
42 PTP1C 68 +++ – – – b
43 PTP1D/SHP2 72 +++ ++ ++ ++ f 3
Tyrosine kinases 
44 Src 60 +++ + + + p 47, 59, 60, 90, 101
45 Fyn 59 +++ – – – f
46 FAK 125 +++ – – – f
47 PYK2 116 +++ + + + f 44
MAP kinase pathway
48 ERK (pan ERK) 42/44 +++ ++ ++ ++ f
49 ERK1 42/44 +++ ++ ++ ++ f
50 ERK2 42 +++ ++ ++ ++ f 57
51 ERK3 62 +++ – – – f
52 phospho-ERK1/2 42/44 +++ – – – q
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53 MEK1 45 +++ ++ ++ + f 59
54 MEK2 46 +++ ++ ++ + f 59
55 MKP2 43 +++ +++ +++ ++ f
56 JNKK1 / MKK4 44 +++ – – – f
57 Rsk 90 +++ ++ ++ ++ f 50
58 Rsk-2 90 +++ ++ +++ + r 50
59 c-Raf1 74 +++ ++ ++ + f 44, 53–54, 60
Small G-proteins and modulators
60 H-Ras 21 +++ cl cl + f 44, 59, 65, 66, 71
61 Rac1 21 +++ ++ + + f 75, 101, 102
62 Rap1 21 +++ – – – f
63 Rap2 21 +++ ++ ++ + f
64 RalA 24 +++ cl cl + f
65 SynGAP 135 +++ ++ ++ ++ e 10, 12, 35, 60
66 NF1 250 +++ + + + r 60, 101
67 p120GAP 120 +++ – – – f
Other signaling molecules
68 Calmodulin 15 +++ +++ +++ +++ b 1, 9, 12, 19, 35, 69, 92
69 nNOS 155 +++ ++ ++ ++ f 10, 11, 35, 68
70 eNOS 140 +++ – – – f
71 PI3 kinase 85 +++ + + + f 3, 60, 101
72 Calpain 30 +++ – – – s
73 PLC γ 150 +++ ++ ++ ++ r 2, 3, 9, 94, 101
74 cPLA2 110 +++ +++ ++ ++ r
75 Citron 183 +++ +++ +++ ++ r 10, 61
76 VAV 95 +++ – – – f
77 Arg3.1 55 +++ +++ +++ +++ t
78 CREB/CREM 46/26 – – – – f
79 NCK 47 +++ – – – f
80 SHC 52/66 +++ – – – f
Cell-adhesion and cytoskeletal proteins
81 N-Cadherin 150 +++ ++ ++ +++ u 81, 87, 88, 90
82 E-Cadherin 120 +++ – – – f
83 P-Cadherin 120 +++ – – – f
84 Cadherin-5 130 +++ – – – f
85 Desmoglein 165 +++ ++ ++ + f 85, 88
86 α-Catenin 102 +++ – – – f 87, 88, 95
87 β-Catenin 92 +++ ++ ++ + f 81, 86
88 γ-Catenin 82 +++ – – – f 85, 86
89 L1 200 +++ +++ +++ ++ f 89
90 pp120cas 120 +++ +++ ++ + f 44, 81
91 Paxillin 68 +++ – – – f
92 MAP2B 280 +++ ++ + + f 25, 68, 101
93 Vinculin 117 +++ – – – v
94 Actin 45 +++ +++ +++ +++ w 73, 95, 96, 97, 102
95 α-actinin 2 110 +++ +++ +++ +++ v 1, 3, 86, 94
96 Spectrin 240/280 +++ ++ ++ ++ v 1, 2, 3, 94, 96
97 Myosin (brain) 205 +++ +++ +++ ++ v 94
98 Tau 50–68 +++ – – – f
99 Tensin 215 +++ – – – f
100 Ezrin 80 +++ – – – f
101 Tubulin 50 +++ +++ +++ +++ v 1, 3, 9, 61, 66, 71, 73, 92, 96, 106
102 Cortactin 80/85 +++ + + ++ x 14, 44, 61, 94, 103
103 CortBP-1 180/200 +++ + ++ +++ x 102
104 Clathrin heavy chain 180 +++ ++ ++ +++ f 106
105 Dynamin 100 +++ ++ ++ +++ f 26–34
106 Hsp-70 70 +++ ++ ++ +++ f 101, 104
Immunoblotting screen of NRC and known binding partners within NMDAR complexes. Classes of proteins are boxed, and specific molecular names are indi-
cated with identifying numbers (1–106). Mr, relative molecular mass; Ex, mouse brain extracts; IA, complexes isolated by MAP–NR1 immunoaffinity; IP, com-
plexes isolated by MAP–NR1 immunoprecipitation; Pep, complexes isolated by NR2B peptide affinity; Ab, antibody source (see Methods); binding partner,
identified interactions from published in vitro studies. Specific brain proteins were assayed in three preparations of complexes (IA, IP, Pep) using
immunoblotting, and signals were scored as strong (+++), medium (++), weak (+) or undetectable (–). Some proteins could not be analyzed in IA or IP
because of comigration of Ig (ch, comigration heavy chain Ig; cl, comigation light chain Ig). The scoring is not suitable for comparison of different proteins
because it depends on the properties of specific antibodies, but it is suitable to indicate a relative enrichment from extract. For each protein found in the
complexes, the reported associated proteins are indicated (binding partners) by reference to the numbering scheme in the first column.
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with NMDAR signaling and scaffolding (Table 1) and protein
identification using mass spectrometry (Fig. 2 and 
Table 2). The protein bands indicated in Fig. 1g were analyzed by
online LC-MS/MS (Fig. 2). It is important to note that these strate-
gies do not show absolute levels and stoichiometry of subunits.
The NMDA and mGlu receptors have been implicated in the
induction of synaptic plasticity through activation of second mes-
senger pathways1,2. We therefore examined a wide range of dif-
ferent kinases and phosphatases in the NRC and found several
specific serine-threonine kinase and phosphatase family mem-
bers. We found protein kinase A (PKA) catalytic subunit and reg-
ulatory subunit R2β (R1, R1α and R2α were not detected) and
protein kinase C (PKC) isoforms β, γ, ε, but not α, δ, η, θ, ι , λ
isoforms. That a subset of a protein family associated with the
NRC, indicating specific association, was observed repeatedly for
multiple classes of proteins in this study. The α and β subunits
of CaMKII were associated, as reported20, and also found to be
in the phosphorylated active form. The presence of these kinas-
es, which are involved in induction of synaptic plasticity, suggests
that counterpart phosphatases may also be present in the NRC.
We found that PP1 and PP2A were strongly associated and PP2B
(calcineurin) and PP5 were also associated. PKA and PP1 are
linked to the NR1 subunit via an adapter protein (Yotiao) and
can modulate NMDAR currents in vitro21. We found Yotiao and
another PKA adaptor, AKAP150, suggesting that PKA may be
linked to the NRC at multiple locations, perhaps in distinct
pathways.
Because tyrosine phosphorylation is also involved with
NMDAR22 and synaptic plasticity23, we examined cytoplasmic
tyrosine kinases and found Src (but not Fyn) and the calcium-
activated kinase Pyk2 (but not the Pyk2 homologue focal adhe-
sion kinase, FAK) associated with the NRC. Although tyrosine
phosphatase inhibitors influence NMDAR channels22, the iden-
tity of relevant tyrosine phosphatases has remained unclear. We
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Table 2. Summary of mass spectrometry analysis of NRC proteins.
Protein name Mr (kD) Accession number Number of peptides
Bassoon 418 O88778 11
Myosin B heavy chain (non muscle type) 229 P35580 27
p53 binding protein-1 214 Q12888 2
Tight junction protein ZO-1 195 P39447 13
Clathrin heavy chain 192 P11442 1
NR2B 166 Q01097 85
NR2A 165 P35436 36
SynGAP 143 AAC08071 9
NR1 105 P35438 208
α-actinin 2 103 Q62744 25
Sap97 100 Q12959 2
Hypothetical 97.8 kD protein 98 CAB43675 3
Dynamin 96 Q61358 4
Chapsyn 110 95 Q63622 108
Sap102 93 P70175 9
Phosphofructokinase 86 P12382 7
NSF vesicular fusion protein 83 P46460 1
PSD-95 80 Q62108 112
APPL adaptor protein 80 AF169797 8
Sarcolemmal associated protein-3 74 Q28623 3
GKAP/SAPAP 74 P97841 4
HSP70-like HS71 protein 71 U73744 24
Kinesin light chain 2 67 O88448 2
PP2A regulatory R1 α chain 65 P30153 1
CaM kinase II β 60 P28652 1
PP2B (Calcineurin) α chain 59 P20652 3
α-Internexin 56 P46660 2
CaM kinase II α 54 P11798 4
RNA binding protein FUS/TLS 53 P35637 1





Visualized protein bands of 60–300 kD were prepared and analyzed as described (Methods and Fig. 2). Mr, relative molecular mass; number of peptides, total
number of matching peptides sequenced by MS/MS for a specific protein. Note that the number of peptides sequenced from each protein does not directly
correlate to quantity of protein. Peptide lengths were 10–20 residues, and the peptides were unique and did not match any other sequences in the databases.
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detected PTP1D/SHP2, which associates with NR2B24, but nei-
ther the related PTP1B or PTP1C in the NRC, implicating this
tyrosine phosphatase in NRC regulation.
How NMDAR-mediated kinase and phosphatase signal inte-
gration occurs is unclear, but the involvement of Ras, which inte-
grates downstream signals in other cellular contexts, is suggested
by the altered plasticity and learning in mice with mutations in
modulators of Ras (Ras-GRF25 or NF1; ref. 26). We found both
H-Ras and Rap2 small G proteins and their GTPase activating
proteins NF1 and SynGAP (which binds PSD-95), but not
p120GAP in the NRC. Rap1, which may couple PKA to c-Raf1,
was not detectable in the NRC. Ras mediates its effects by differ-
ential activation of several downstream effector pathways27,
including the c-Raf1–MEK–ERK/MAPK pathway, PI3 kinase and
RalA. The different MAPK pathways are organized into modules
composed of the key enzymes producing that cascade, tethered
within a cell to produce signal specificity28. This was also the case
for the NRC, as ERK1 and ERK2 and their upstream activating
kinases MEK1, MEK2 and c-Raf1 were found, but not
JNKK1/MKK4 and ERK3. Moreover, the ERK phosphatase
(MKP2), which inactivates ERK, was also identified. In addition
to ERK/MAPK pathway, mass spectrometry identified APPL29,
an adaptor protein linking the p110 subunit of PI3 kinase to
AKT/PKB kinase. These observations that ERK/MAPK and the
other Ras effectors, PI3 kinase and Ral were detected along with
adaptors and regulators indicates that glutamate receptors drive
Ras, which is coupled to distinct downstream pathways organized
as modules within the NRC.
The role of ERK/MAPK pathways in synaptic plasticity and
learning has received considerable attention because phospho-
rylation of ERK accompanies these processes, which are also dis-
rupted by inhibitors of MEK30. Phosphorylation of ERKs has
mainly been implicated in regulating transcription, through phos-
phorylation of Rsk-2, which translocates to the nucleus to phos-
phorylate transcription factors CREB and CREM. Interestingly,
phospho-ERK was not present in the NRC, although it was read-
ily detected in the extract, consistent with its ability to translo-
cate from the NRC on phosphorylation. Moreover, Rsk-2 was
found within the NRC, although the transcription factors CREB
and CREM were not detectable. We noticed that several of the
NRC proteins (Homer, NR1, NR2B, PKCγ, ERK2, c-Raf1, HSP70)
are encoded by activity-dependent genes, and we therefore test-
ed Arg3.1/Arc31,32, a postsynaptic protein of unknown function
that is also rapidly regulated by LTP. Arg3.1 was readily detected
in the NRC, suggesting it may participate in signaling and dynam-
ic organization of the NRC. Thus the NRC contains signaling
mechanisms that could contribute to transcriptional activation
following synaptic activation, and the NRC could then itself
undergo structural changes secondary to altered gene expression.
Another potential ERK effector, cPLA33, is also regulated by Cit-
ron, which binds PSD-95. Mice lacking cPLA2 show resistance
to ischemic neuronal damage34, and cPLA2 generates arachidonic
acid, a candidate transynaptic retrograde signaling molecule.
Changes in synapse structure may be fundamental to the stor-
age of long-term memory, and roles for cell-adhesion molecules
and cytoskeletal structural proteins in this process are suggest-
ed35. Many of the signaling proteins described above are known
regulators of cytoskeleton and cell adhesion. Actin cytoskeleton is
involved in NMDAR channel properties36, NMDAR-mediated
LTP37 and NMDAR localization38, and is dynamically regulated
in spines by neural activity39. We found α-actinin 2 and spectrin
(Fodrin), which bind NMDAR subunits40, and actin–binding
proteins, including cortactin, cortactin–binding proteins
(CortBP1 and Shank) and MAP2, but not Ezrin, Tensin or Vin-
culin, in the NRC. Surprisingly, the cell-adhesion proteins N-
Cadherin and Desmoglein, two cadherin family members and
their cytoplasmic interacting proteins β-catenin, ZO-1 and
p120cas were detected, although E-cadherin, P-cadherin, cad-
herin-5, α-catenin and γ-catenin were negative. L1 adhesion pro-
tein, which is required for learning and synaptic plasticity41, was
also detected in the NRC. These adhesion proteins may be
involved in structural organization of the NRC at the synapse;
however, the involvement of cadherins42 and L1 in synaptic plas-
ticity41 make it tempting to speculate that this glutamate recep-
tor–cell-adhesion protein complex could provide multiple
trans-synaptic signaling pathways, whereby adhesion-mediated
signaling is coupled to transmitter signaling mechanisms.
Mass spectrometry of large-scale isolated NMDAR complex-
es has confirmed and extended the identification of NRC com-
ponents beyond yeast 2-hybrid assays and immunoblotting
(Tables 1 and 2). Some NRC components were not detected by
MS, which may be due to the low levels of protein in the selected
gel fragments. In addition to identification of previously unsus-
pected known proteins, the MS approach also identified match-
ing peptides that are represented in the dbEST database,
indicating novel proteins in the NRC. During the course of this
work, as the databases expanded, several EST matches were sub-
sequently found to match known proteins. For example, the pep-
tide sequence DLKEILTLK (Fig. 2d) was originally identified as
mouse hippocampus EST (AV153731), and later a report of the
full-length cDNA sequence allowed us to match with seven other
peptides, thus identifying this NRC protein as APPL, a novel
adaptor for PI3 kinase and AKT/PKB29. Although it is clear that
some protein complexes contain dozens of proteins11,12, the large
number of NRC proteins identified in this study does not imply
that all proteins exist in a single homogeneous complex. Het-
erogeneity could result from different complexes in the starting
material, as may be found at different synapses. Moreover, the
large size of the complex may reflect dynamic assembly, perhaps
involving activity-dependent genes, or transient protein–protein
interactions of signaling complexes, which is a feature of many
signaling pathways involving the proteins in the NRC6.
DISCUSSION
The proteomic approach complements and extends studies using
yeast two-hybrid screens for the identification of proteins in neu-
rotransmitter receptor complexes. Fourteen proteins that inter-
act with NR1 and NR2, as determined by two-hybrid screens,
also coimmunoprecipitate with NMDAR from brain (PSD-95,
Chapsyn110/PSD-93, SAP102, GKAP/SAPAP, Yotiao, SynGAP,
Calmodulin, nNOS, PI3-kinase, Citron, MAP2B, actin, 
α-actinin2, spectrin). Twelve proteins interact with these 14 pro-
teins, but were not formally shown to exist in NRCs (mGluR,
GluR6/7, Homer/Vesl1, Shank, PKA-R2β, PP1, PKA catalytic
subunit, PLCγ, Cortactin, CortBP-1, phosphofructokinase,
APPL). Four proteins coimmunoprecipitate with NMDARs with-
out defined interaction domains (CaMKII, Src, PTP1D/SHP2,
tubulin). All 30 of these proteins were detected in our analysis,
including PI3 kinase, which interacts via SH2 phosphorylation
with NR2 and therefore escapes detection in two-hybrid screens.
We identified a third group of 19 proteins, not previously known
to be structurally linked to NRCs, but functionally implicated in
NMDAR-dependent synaptic plasticity, including PKC (β, γ, ε),
PP2A, PP2AR1α , PP2B, NF1, Ras, Rap2, c-Raf1, MEK1/2,
ERK1/2, MKP2, Rsk-2, cPLA2, N-cadherin, L1, Arg3.1/Arc and
HSP70. A fourth set of six proteins that were not structurally or
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functionally linked to NMDAR but are known to interact with
the above proteins include β-Catenin, Z0-1, pp120CAS, myosin,
Clathrin and Dynamin. There remains a set of 19 proteins,
including 5 ESTs, Pyk2, AKAP150, PP5, Rac1, RalA, NSF, SAP97,
Desmoglein, Bassoon, P53 binding protein, Sarcolemmal asso-
ciated protein-3, Kinesin light chain, RNA binding protein
FUS/TLS and α-internexin. Interestingly, this latter set includes
proteins that might be involved in postsynaptic receptor traf-
ficking and spine translational regulation.
The structure of the NRC isolated from the mouse brain indi-
cates that subsets of neurotransmitter receptors, cell-adhesion
proteins, adapters, second messengers and cytoskeletal proteins
are organized together into a physical unit comprising signaling
pathways. Several features of the NRC provide insights into the
specific functions of this complex, particularly in the physiologi-
cal context of NMDAR-dependent synaptic plasticity. The sim-
plest general function for this NRC may be in the ‘induction phase’
of synaptic plasticity in contrast to the ‘expression phase’ as
described in electrophysiological experiments. Induction involves
activation of the NMDAR and mGluR, Ca2+ influx and second
messenger signaling and occurs within the first hour after the train
of stimuli. Expression or maintenance of synaptic plasticity after
one hour is resistant to inhibition of NMDAR or second messen-
gers and is mediated by AMPA receptors. Thus the NRC contains
the molecular machinery for the induction of plasticity, and
AMPA receptor complexes are separate entities mediating expres-
sion. The assembly of specific signaling modules composed of
effector pathways (for example, Ras-ERK/MAP or Ras-PI3 kinase)
might regulate specific components of LTP or LTD. In addition
to trafficking and phosphorylation of AMPA receptors, the expres-
sion of plasticity is reported to involve multiple cellular mecha-
nisms, including cytoskeletal changes in spine structure, local
translation regulation and gene transcription. These functions
could be linked to the NMDA receptor via the NRC proteins.
This model of the NRC as an induction device is supported
by targeted mouse mutations, transgenic expression and phar-
macological inhibition of NRC proteins that alter the induction
of synaptic plasticity. Induction of synaptic plasticity is altered
by targeted mouse mutations in NR1, NR2A, mGluR1, PSD-95,
PKA catalytic and regulatory subunits, PKCγ, CaMKII, nNOS,
NF1 or H-Ras, by transgenic expression of NR2B, CaMKII, PP2B,
PKA inhibitors or L1, and by pharmacological inhibition of
NMDAR, mGluR, PKA, PKC, CaMKII, MEK, tyrosine kinases,
PP1, PP2A, PP2B, Cadherins, L1, actin polymerization, Calmod-
ulin, nNOS, PI3 kinase or cPLA2. A physiological parallel with
these disruptions in NRC proteins is observed during postnatal
development of the hippocampus and cortex. The threshold for
NMDAR-mediated LTP and LTD is age dependent2, and during
this time the levels of expression of many NRC proteins and their
association into NMDAR complexes changes43. The NRC is also
well suited to induce bidirectional synaptic plasticity (LTP and
LTD) because many calcium-sensitive proteins with kinases and
phosphatases are beneath the NMDAR calcium pore in a
microdomain. The composition of this complex goes some way
to addressing questions raised5 regarding the apparent diversity of
molecules involved with synaptic plasticity, as a substantial sub-
set of these molecules are components of the NRC and map onto
the function of induction.
In addition to a role in synaptic plasticity, the NRC described
here is likely to be important for cognitive function and in par-
ticular learning and memory. Learning impairments in rodents
are associated with genetic and pharmacological disruption of
multiple components of the NRC (NR1, NR2A, NR2B, PSD-95,
PKA subunits, PKC isoforms, CaMKII, PP1, PP2A, PP2B, MEK,
NF1, nNOS, cPLA2 and L1). Although these data support a role
for the NRC in both learning and synaptic plasticity, it may be
premature to conclude that synaptic plasticity is itself required
for learning, as the NRC seems to comprise multiple effector
pathways, which may be differentially required for learning or
plasticity or other cellular processes44. Because the term NRC was
used to describe the channel formed by NMDAR subunits, ‘Heb-
biasome’ or ‘potentiosome’ are alternative terms describing the
function of the described complexes in controlling synaptic
potential and Hebbian synaptic properties.
We were surprised to find that three of the proteins (NF1,
ref. 45; L1, ref. 46; Rsk-2, ref. 47) detected in this proteomic
study were encoded by genes that underlie human mental retar-
dation and learning impairment. This implies that the defect in
these patients is in the function of the NRC. Moreover, these
findings suggest that pharmacological manipulation of the
NRC, as distinct to NMDARs alone, may provide new thera-
peutic avenues for these patients. Proteomic tools combined
with genetic dissection of the NRC signaling pathways in
mutant mice should lead to an understanding of the specific
contributions of each pathway to the cellular mechanisms of
synaptic plasticity and learning, as well as provide a new route
toward understanding human neuropsychiatric conditions.
METHODS
Antibodies. Affinity-purified NR1-specific sheep polyclonal antibodies
(MAP-NR1) were generated using a multiple-antigen peptide (MAP)
of the last 20 amino acids of NR1 ((H-RRAIEREEGQLQLCSRHRES)8-
MAP; Diagnostics Scotland, Carluke, UK). Antibody sources (column
Ab in Table 1): a, J.H. Morrison; b, Upstate Biotech, Waltham,
Massachusetts; c, Chemicon, Wealdstone, UK; d, Pharmingen, San
Diego, California; e, R. Huganir; f, Transduction Laboratories,
Lexington, Kentucky; g, M. Watanabe; h, Alomone Labs, Jerusalem,
Israel; i, H. Kreienkamp; j, K. Inokuchi; k, E. Ziff; l, J. Scott; m, 
J. Henley; n, Promega, Madison, Wisconsin; o, P. Cohen; p, Oncogene,
Nottingham, UK; q, New England Biolabs, Hitchin, UK; r, Santa Cruz
Biotechnology, Santa Cruz, California; s, Calbiochem, Nottingham,
UK; t, D. Kuhl; u, D. Coleman; v, Sigma, Poole, UK; w, Roche Molecular
Biochemicals, Lewes, UK; x, J. Parsons.
Purification of the NMDAR complex. The receptor complex was isolated
from mouse forebrain extracts using covalently coupled MAP-NR1
immunoaffinity resins, immunoprecipitation with the same antibody, or
peptide-affinity chromatography with a hexapeptide of the NMDA-R2B
C-terminus (SIESDV; H.H. and S.G.N.G., unpublished data). In brief,
samples were homogenized in 1% (w/v) deoxycholate-containing buffer
at pH 9.0, spun for 30 minutes at 50.000 × g at 4ºC, followed either by
incubation with MAP-NR1 antibody and subsequent protein G-sepharose
precipitation, or by immunoaffinity chromatography using MAP-NR1
antibody–substituted affigel-10 (BioRad, Hemel Hempstead, UK; 5 mg
antibody per ml resin), or the NR2B peptide resin (5 mg peptide per ml
affigel-10 resin). The resins were washed after an overnight incubation at
4ºC with 100 to 1000 column volumes of extraction buffer at 4ºC, and pro-
teins were separated from the resin by boiling in 4% SDS for 30 minutes.
Western blotting. Samples were separated by SDS-PAGE and transferred
to PVDF membrane at 4ºC for 90 minutes at 75 V in 10% (v/v) methanol
and 10 mM CAPS, pH 11.0. Dilution of primary antibodies was between
1:100 and 1:1000 depending on the quality of the IgG. Signals were
detected using peroxidase-linked secondary IgGs and enhanced chemi-
luminescence.
Mass spectrometry sample preparation. NMDAR complex samples were
separated by SDS-PAGE and stained by Coomassie blue or silver stain-
ing48. Individual protein bands of 60–300 kD were excised, reduced, alky-
lated and digested with trypsin49. The resultant peptide mixtures were
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analyzed by on-line liquid chromatography tandem mass spectrometry
(LC-MS/MS) to generate peptide sequence information50.
Online LC-MS/MS analysis. Chromatographic separations of the pep-
tide mixture were done on a 180 µm PepMap column using an Ultimate
LC system (LC Packings, Amsterdam, Netherlands) delivering a gradi-
ent to formic acid (0.05%) and acetonitrile. The eluting peptides were
ionized by electrospray ionization on a Q-TOF hybrid mass spectrome-
ter (Micromass, Wythenshawe, UK) fitted with a Z-spray source. The
instrument, in automated switching mode, selects precursor ions based
on intensity for peptide sequencing by collision-induced fragmentation
tandem MS. The MS/MS analyses were conducted using collision energy
profiles that were chosen based on the m/z of the precursor; a total of
nine MS/MS scans were acquired per precursor. Several hundred MS/MS
spectra were generated per run, allowing the analysis of complex mix-
tures without any prior interpretation. The mass spectral data was
processed into peak lists containing m/z value, charge state of the par-
ent ion, fragment ion masses and intensities, and correlated with pro-
teins and nucleic acid sequence databases using Mascot software (Matrix
Science, London, UK). Proteins were identified based on matching the
MS/MS data with mass values calculated for selected ion series of a pep-
tide. A non-redundant protein database and a nucleotide database
(dbEST) were searched without applying any constraints on molecular
weight or species. Most proteins were identified with several peptide
matches, although a few were assigned on the basis of a single peptide
provided near-complete peptide sequence had been obtained.
Note: A complete list of references for all protein interactions can be found on the
Nature Neuroscience web site (http://www.nature.com/neuro/web_specials/).
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